Myriad Genetics (MYGN) Share-based Compensation Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 1.23% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 2.20% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 8.31% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 58.33% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 5.80% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -0.20% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 500.00% |
| 10 | Myriad Genetics | 296.09 Mn | 171.69 Mn | 137.60 Mn | -31.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.58% |
| Dec 31, 2025 | -92.55% |
| Sep 30, 2025 | -1.61% |
| Jun 30, 2025 | -26.21% |
| Mar 31, 2025 | 9.20% |
| Dec 31, 2024 | 274.88% |
| Sep 30, 2024 | 6.90% |
| Jun 30, 2024 | 29.46% |
| Mar 31, 2024 | 16.00% |
| Dec 31, 2023 | -1,533.33% |
| Sep 30, 2023 | 23.40% |
| Jun 30, 2023 | 7.69% |
| Mar 31, 2023 | -25.74% |
| Dec 31, 2022 | 109.15% |
| Sep 30, 2022 | -65.57% |
| Jun 30, 2022 | 10,300.00% |
| Mar 31, 2022 | 1,920.00% |
| Dec 31, 2021 | -210.07% |
| Sep 30, 2021 | 225.00% |
| Jun 30, 2021 | -98.94% |